SRPT icon

Sarepta Therapeutics

Buy
Hold
Sell

21 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$22
2% downside
High target

21 analyst ratings

positive
11  neutral
52%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
BMO Capital
BMO Capital
Kostas Biliouris
100% 1-yr SRPT win rate
22 Sep ‘25 23 days ago
Guggenheim
Guggenheim
Debjit Chattopadhyay
50% 1-yr SRPT win rate
15 Sep ‘25 1 month ago
Leerink Partners
Leerink Partners
Joseph Schwartz
9 Sep ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
70% 1-yr SRPT win rate
25 Aug ‘25 1 month ago
BofA Securities
BofA Securities
Tazeen Ahmad
0% 1-yr SRPT win rate
21 Aug ‘25 1 month ago
Deutsche Bank
Deutsche Bank
David Hoang
33% 1-yr SRPT win rate
15 Aug ‘25 2 months ago
Goldman Sachs
Goldman Sachs
Salveen Richter
0% 1-yr SRPT win rate
7 Aug ‘25 2 months ago
Wells Fargo
Wells Fargo
Yanan Zhu
33% 1-yr SRPT win rate
7 Aug ‘25 2 months ago
Barclays
Barclays
Gena Wang
0% 1-yr SRPT win rate
30 Jul ‘25 2 months ago
Bernstein
Bernstein
William Pickering
29 Jul ‘25 2 months ago
Piper Sandler
Piper Sandler
Biren Amin
0% 1-yr SRPT win rate
29 Jul ‘25 2 months ago
Morgan Stanley
Morgan Stanley
Matthew Harrison
0% 1-yr SRPT win rate
29 Jul ‘25 2 months ago
Oppenheimer
Oppenheimer
Hartaj Singh
50% 1-yr SRPT win rate
29 Jul ‘25 2 months ago
JP Morgan
JP Morgan
Anupam Rama
0% 1-yr SRPT win rate
29 Jul ‘25 2 months ago
Needham
Needham
Gil Blum
29% 1-yr SRPT win rate
29 Jul ‘25 2 months ago
Jefferies
Jefferies
Andrew Tsai
33% 1-yr SRPT win rate
24 Jul ‘25 2 months ago
Citigroup
Citigroup
Yigal Nochomovitz
0% 1-yr SRPT win rate
24 Jul ‘25 2 months ago
UBS
UBS
Eliana Merle
21 Jul ‘25 2 months ago
Mizuho
Mizuho
Uy Ear
0% 1-yr SRPT win rate
21 Jul ‘25 2 months ago
Leerink Swann
Leerink Swann
Mani Foroohar
21 Jul ‘25 2 months ago
RBC Capital
RBC Capital
Brian Abrahams
0% 1-yr SRPT win rate
17 Jul ‘25 3 months ago
Baird
Baird
Brian Skorney
25% 1-yr SRPT win rate
17 Jul ‘25 3 months ago